Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Carcinogenicity

Currently viewing:

Administrative data

Endpoint:
carcinogenicity: oral
Type of information:
experimental study
Adequacy of study:
other information
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: Test performed on the whole leaf extract of Aloe barbadensis Miller [Aloe vera]
Remarks:
aloin is a constituent of the whole leaf extract of Aloe barbadensis Miller [Aloe vera]

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2013

Materials and methods

GLP compliance:
yes

Test material

Test animals

Species:
rat
Strain:
Fischer 344
Sex:
male/female
Details on test animals or test system and environmental conditions:
48 male and 48 female F344/N

Administration / exposure

Route of administration:
oral: drinking water
Vehicle:
water
Details on exposure:
drinking-water containing whole leaf extract of Aloe barbadensis Miller [Aloe vera] at 0 (controls), 0.5%, 1.0%, or 1.5% (wt/wt)
Duration of treatment / exposure:
2 years
Control animals:
yes

Results and discussion

Applicant's summary and conclusion

Conclusions:
In a 2-year study of carcinogenicity, groups of 48 male and 48 female F344/N rats were given drinking-water containing whole leaf extract of Aloe barbadensis Miller [Aloe vera] at 0 (controls), 0.5%, 1.0%, or 1.5% (wt/wt) for 104 weeks. The average content of aloin A and aloe-emodin of the whole leaf test material was 6.40 and 0.071 mg/g, respectively. The doses of whole leaf extract were equivalent to average daily doses of approximately 0, 0.2, 0.6, or 1.1 g/kg bw in males and 0, 0.3, 0.7, or 1.3 g/kg bw in females. Survival of exposed groups was similar to that of controls. Whole leaf extract caused increased incidences of adenoma and carcinoma of the large intestine (colon and caecum) in males and females. Other treatment-related lesions included hyperplasia and/or inflammation in the mesenteric lymph node, forestomach, small intestine, and large intestine in males and females.